AstraZeneca CEO Soriot Pursues Multip...

AstraZeneca CEO Soriot Pursues Multiple Strands in RNA Drug Discovery Push

There are 1 comment on the Bloomberg story from Mar 27, 2013, titled AstraZeneca CEO Soriot Pursues Multiple Strands in RNA Drug Discovery Push. In it, Bloomberg reports that:

AstraZeneca Plc , whose setbacks in drug development have made the stock the cheapest among the largest pharmaceutical companies, is turning to RNA technology to boost its chances of discovering new therapies.

Join the discussion below, or Read more at Bloomberg.

Robert sam Burke

Bear Creek, NC

#1 Mar 31, 2013
I was recently told that there is a generic durg for NEXIUM called Izra-40 (Esomeprazole Tablets IP 40) IS THIS TRUE AND WHERE CAN I BUY.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Mumps outbreak probably isn't related to vaccin... Apr 18 MMR 1
News Bristol Palin says abstinence best path for teens (May '09) Apr 3 Coonway Tweety 2,658
News After Trump rally, equity investors move into h... Mar '17 Retribution 6
News N/R: Lack of mental, epileptic drugs hit health... Mar '17 Humanspirit 1
News The EpiPen debacle may be the shot heard around... Feb '17 Suezanne 2
News Despite $19 million salary, Mylan CEO failed to... (Sep '16) Feb '17 Suezanne 3
News Myriad Genetics Announces an Assay that Identif... Feb '17 Purplemouse2 8
More from around the web